CC(=O)O[C@@H]1C[C@](C)(OC(C)=O)C[C@H]2[C@]3(C)[C@@H](OC(C)=O)[C@@]4(O)C[C@H](C)[C@H](OC(=O)c5ccccc5)[C@@H]4[C@@H](OC(C)=O)[C@]3(C)C[C@@]21OC(C)=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?